High Glucose Variability Increases Mortality Risk in Hospitalized PatientsAmit Akirov(Rabin Medical Center), Ilan Shimon(Tel Aviv University)The Journal of Clinical Endocrinology & MetabolismMarch 22, 201710.1210/jc.2017-00450Cited by 66SaveCiteExport RISWatch citationsRelated PapersMammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro|Endocrine Related Cancer|2009|78